Corrigendum to “Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2” [Bioorg. Med. Chem. Lett. 18 (2008) 4267–4274]

Corrigendum to ‘‘Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2” [Bioorg. Med. Chem. Lett. 18 (2008) 4267–4274] Erin F. DiMauro *, John L. Buchanan , Alan Chen , Renee Emkey , Stephen A. Hitchcock , Liyue Huang , Ming Y. Huang , Brett Janosky , Josie H. Lee , Xingwen Li , Matthew W. Martin , Susan A. Tomlinson , Ryan D. White , Xiao Mei Zheng , Vinod F. Patel , Robert T. Fremeau Jr. e